Form 4: UL Solutions Director Reports Stock Unit Accrual
Insider Transaction Report
UL Solutions Director Elisabeth Torstad reported the accrual of dividend equivalent rights on deferred restricted stock units, increasing her beneficial ownership.
Summary
- Elisabeth Torstad, a Director at UL Solutions Inc. (ULS), reported changes in her beneficial ownership of derivative securities.
- She accrued 8 Deferred Restricted Stock Units (DRSUs) representing dividend equivalent rights on March 12, 2026, bringing her total beneficial ownership of this type to 4,962 DRSUs. These units vested on May 1, 2025, and are expected to be settled in Class A Common Stock according to the company's Non-Employee Director Deferred Compensation Plan.
- She also accrued an additional 4 DRSUs representing dividend equivalent rights on March 12, 2026, bringing her total beneficial ownership of this type to 2,805 DRSUs. These units will vest on the earlier of May 20, 2026, or the date of the annual meeting following the grant date, and are also expected to be settled in Class A Common Stock under the same plan.
- Each deferred restricted stock unit represents a contingent right to receive one share of UL Solutions' Class A Common Stock.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event, reflecting routine compensation accrual for a director, which aligns their interests with shareholders without indicating any significant operational or financial changes.
Positives
- The accrual of dividend equivalent rights increases the director's beneficial ownership in the company, aligning her interests with shareholders.
- The vesting of 8 DRSUs on May 1, 2025, indicates a portion of her compensation has matured and is awaiting settlement.
Future Outlook
The deferred restricted stock units are expected to be settled in shares of UL Solutions' Class A Common Stock either on a date selected by the reporting person or as otherwise provided by the Issuer's Non-Employee Director Deferred Compensation Plan.
Industry Context
StockSavvy.ai notes that the accrual of dividend equivalent rights on restricted stock units is a standard component of non-employee director compensation packages across various industries, designed to align director interests with long-term shareholder value.
Stakeholder Impact
- Shareholders: The director's increased beneficial ownership aligns her interests with shareholders, potentially fostering long-term value creation.
Next Steps
- Settlement of the 8 deferred restricted stock units (vested May 1, 2025) in Class A Common Stock, as per the Non-Employee Director Deferred Compensation Plan.
- Vesting of the 4 deferred restricted stock units on the earlier of May 20, 2026, or the date of the annual meeting following the grant date.
- Subsequent settlement of these 4 deferred restricted stock units in Class A Common Stock, as per the Non-Employee Director Deferred Compensation Plan.
Key Dates
| Date | Description |
|---|---|
| 2025-05-01 | Vesting date for 8 deferred restricted stock units, which are expected to be settled in shares. |
| 2026-03-12 | Date of accrual of dividend equivalent rights on deferred restricted stock units for Elisabeth Torstad. |
| 2026-03-16 | Date the Form 4 was signed by Attorney-in-Fact Ryan Robinson. |
| 2026-05-20 | Latest vesting date for 4 deferred restricted stock units, or earlier if the annual meeting occurs before this date. |
Recommendation
holdThis Form 4 filing reports a routine accrual of deferred restricted stock units as part of a director's compensation. Such transactions are expected and do not typically signal a change in the company's fundamental outlook or warrant a change in investment recommendation. It primarily serves to update beneficial ownership records.
Keywords
UL Solutions, ULS, Form 4, Insider Transaction, Elisabeth Torstad, Director, Deferred Restricted Stock Units, DRSU, Dividend Equivalent Rights, Beneficial Ownership, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.